Skip to content
2000
Volume 11, Issue 6
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality in the world because current treatments, including both surgical and non-surgical ones, cannot effectively cure this disease. Increasing evidence has revealed the importance of cancer stem cells (CSCs) in hepatocarcinogenesis, and the idea of targeting CSCs sheds light on more effective therapeutic strategies for HCC. In this review, normal stem cells and putative CSCs in the liver are briefly introduced. Studies about signaling pathways that regulate pathophysiological activities of liver CSCs and the therapeutic potential by targeting CSCs are also summarized and discussed.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/187152011796011091
2011-07-01
2025-04-02
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/187152011796011091
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test